An official website of the United States government
          Here’s how you know
        Here’s how you know**Official websites use .gov**A
              **.gov** website belongs to an official government
              organization in the United States.
        **Secure .gov websites use HTTPS**A
              **lock** (
              Locked padlock icon) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
 Top Utility Nav
        
        
        Asian-Language Resources
        
        Portal en español


Site search Mega Menu
  

        

        Home
                  Health Topics
                                      
    
  Health Topics

    Arthritis and Rheumatic Diseases
          
    Muscle and Bone Diseases
          
    Skin Diseases
          
    All Diseases and Conditions
          
    Publication Catalog
                  Grants & Funding
                                      
    
  Grants & Funding

    Current Funding Opportunities
          
    Supported Scientific Programs
          
    NIAMS-Supported Programs
          
    Applying for a Grant
          
    NIH Policies and Guidance
          
    Peer Review and Grants Administration Resources
          
    Types of Funding Mechanisms (Activity Codes)
                  Labs @ NIAMS
                                      
    
  Labs @ NIAMS

    NIAMS Labs and Core Facilities
          
    Research Faculty
          
    Research Areas
          
    NIAMS Scientific Advances
          
    Training and Career Development
                  Clinical Trials
                                      
    
  Clinical Trials
      
            For Principal Investigators

    Clinical Trial Policies, Guidelines, and Templates
          
    Conducting Clinical Trials
          
    Register with ClinicalTrials.gov

For Patients

What is a Clinical Trial?
	Clinical Trials at NIAMS
	Clinical Trials in the Spotlight
                  News & Events
                                      
    
  Newsroom

    All NIAMS News
          
    NIAMS Newsletters
          
    Meetings & Events
                  About NIAMS
                                      
    
  About NIAMS

    Director's Page
          
    NIAMS Organization
          
    Strategic Plan Fiscal Years 2020-2024
          
    Staff Directory
          
    NIAMS Budget
          
    Partnerships
          
    Contact NIAMS
                  Community Outreach
                                      
    
  Community Outreach

    Bone Health
          
    Joint Health
          
    Muscle, Tendon, and Ligament Health
          
    Skin Health
          
    Health Information For Kids And Young Adults
          
    Health Information For Older Adults/Seniors
          
    Printable Materials for Community Events
          
    Resources in Other Languages
          
    Annual Health Observances
          
    Social Media Resources Breadcrumb
    Home
          Newsletters
          NIAMS Update
          NIAMS Update, Issue 2, 2022


NIAMS Update


NIAMS Update, Issue 2, 2022


NIAMS Update, Issue 2, 2022: Science News | Events | Funding Opportunities *April 28, 2022*
      FacebookEmailPrintFacebookEmail 
    The NIAMS Update is produced and distributed by the NIAMS Science Communications and Outreach Branch. It is an online resource for the NIAMS Coalition, Council, and Colleagues.

SPOTLIGHT

Deputy Director’s Letter: *Piecing Together the Autoimmune Disease Puzzle*

Image
              Robert H. Carter, M.D.In her December 2021 letter, NIAMS Director Lindsey Criswell, M.D., M.P.H., D.Sc., discussed the launch of the Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) program. This new initiative builds upon the progress of the prior AMP RA/SLE project, which greatly advanced our understanding of the mechanisms that drive disease in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).



NEWS

Fiscal Year (FY) 2022 Funding Plan

NIAMS is operating under the FY 2022 Consolidated Appropriations Act. The interim funding plan for research and training grants represents the most current information as of the date cited on this web page; however, many factors occurring throughout the fiscal year can affect the operating policies; thus, they are subject to change. For clarification, it is always best to check with an appropriate Institute official.

COVID-19 Updates

Get the latest public health information from the Centers for Disease Control and Prevention, and the latest funding opportunities and research news from the National Institutes of Health (NIH). Additional news and resources include:

How COVID-19 Immunity Holds Up Over Time (NIH Director’s Blog)
	People From Racial, Ethnic, and Other Groups Report Frequent COVID-19–Related Discrimination (NIH)
	Mandatory Masking in Schools Reduced COVID-19 Cases During Delta Surge (NIH)
	NIH Launches Trial to Study Allergic Reactions to COVID-19 mRNA Vaccine (NIH)NIH Director’s Blog: *Unraveling the Role of the Skin Microbiome in Health and Disease*



Image
              NIH Director’s Blog: Unraveling the Role of the Skin Microbiome in Health and Disease


As guest author, NIAMS Director Dr. Lindsey Criswell highlights the research of Heidi Kong, M.D., M.H.Sc., Head of the NIAMS Intramural Research Program’s (IRP) Cutaneous Microbiome and Inflammation Section of the Dermatology Branch, and Richard Gallo, M.D., a NIAMS grantee. Their research is rapidly advancing our understanding of the role of the skin microbiome―and suggesting potential therapeutic opportunities.



A New View of How Muscles Move



Image
              Brian Glancy, Ph.D


Brian Glancy, Ph.D., is an Earl Stadtman Investigator with a dual appointment between NIAMS and the National Heart, Lung, and Blood Institute (NHLBI) at NIH. While examining mouse muscle using high-powered microscopes, he discovered “branching” in the structure and function of myofibrils, the parts of skeletal muscle cells that are key to muscle contraction. His groundbreaking discoveries are expected to change how textbooks depict myofibril structure and function.



New Web Application to Study Cellular Responses to Glucocorticoids



Image
              Luis Franco, M.D.


A new web tool that will allow scientists to study how different human cell types will respond to glucocorticoids (a powerful class of steroid drugs) was developed by Luis Franco, M.D.’s Functional Immunogenomics Labin NIAMS IRP and by scientists with the National Institute of Allergy and Infectious Diseases (NIAID).



What Our Proteins Can Tell Us About Autoimmune Diseases



Image
              Adeline Chin


Adeline Chin, a postbaccalaureate research fellow in the Juvenile Myositis Pathogenesis and Therapeutics Unit in NIAMS IRP, describes the team’s research progress in understanding juvenile dermatomyositis and identifying better and safer treatments with fewer side effects.



How Skin Cells Help Fight Acne



Image
              How Skin Cells Help Fight Acne


NIAMS-supported investigators found that a type of skin cell called a dermal fibroblast can make an antimicrobial compound in response to infection by acne-causing bacteria. The results suggest approaches that could lead to better treatment options for acne.



FDA’s Center for Drug Evaluation and Research (CDER) Continues to Make Rare Diseases a Priority With Drug Approvals and Programming to Speed Therapeutic Development

This article outlines activities of the U.S. Food and Drug Administration’s (FDA) CDER with respect to supporting rare disease drug development.

FUNDING OPPORTUNITIES

Limited Competition: *Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Optional)**(Reissue of RFA-RM-21-022)*

Application due date: May 23, 2022

Immune Drivers of Autoimmune Disease (IDAD) (U01, Clinical Trial Not Allowed) (RFA-AI-22-012)

Application due date: July 1, 2022

Notice of Special Interest: *Promoting Research on COVID-19 and Rheumatic, Musculoskeletal, and Skin Diseases**(NOT-AR-22-012)*

Multiple due dates through January 7, 2023

Notice of NIAMS’ Participation in PA-18-935 “Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement ‒ Clinical Trial Optional)” (NOT-AR-21-028)

Expiration date: October 25, 2022

Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) (PAS-21-245)

Next application due date: June 16, 2022

NIH HEAL Initiative®: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed) (RFA-NS-21-029)

Next application due date: June 9, 2022

Stay Updated About Funding Announcements

If you would like information about grants and funding opportunities, subscribe to funding-dedicated email newsletters, including periodic NIAMS Funding Alerts and a monthly NIAMS Funding News email, and follow our Twitter account (@NIAMSFunding) focused on funding opportunities. Also check out the NIH Guide for Grants and Contracts, the primary source for information about NIH funding opportunities. You can also request a weekly Table of Contents from the NIH Guide. In addition, the NIAMS website provides comprehensive information on NIAMS-related grants and processes.

RESOURCES

Spotlight on Scientific Imagery: Staphylococcus Epidermidis Bacteria



Image
              NIAID researchers discovered how a bacterium that lives on the skin, called S. epidermidis


NIAID researchers discovered how a bacterium that lives on the skin, called S. epidermidis, (shown in green) helps protect the skin from water loss and damage. The research may lead to probiotic treatments to promote skin health during aging or may help treat some skin diseases. The research team is hoping next to test the approach in clinical trials in people.

*Photo credit: NIAID*



Updated NIAMS Resources Available in Spanish, Chinese, Korean, and Vietnamese



Image
              Four pictures, first one lady pushing a wheel barrel, second lady smiling at camera, third couple jogging, fourth construction worker working with hands


*Living With Arthritis, Living With Back Pain* (new), and *Living With Lupus* are now available in Spanish, Chinese, Korean, and Vietnamese. Designed for patients and their families, these resources all can be viewed in full color.

*Living With Arthritis:* Spanish, Chinese, Korean, and Vietnamese
	*Living With Back Pain:* Spanish, Chinese, Korean, and Vietnamese
	*Living With Lupus:* Spanish, Chinese, Korean, and Vietnamese

Nutritional Approaches for Musculoskeletal Pain and Inflammation



Image
              Nutritional Approaches for Musculoskeletal Pain and Inflammation


NIH’s National Center for Complementary and Integrative Health (NCCIH) provides evidence-based information on clinical guidelines, scientific literature, and information for patients for a number of supplements that people consider using for musculoskeletal pain and inflammation, including willow bark, omega-3 fatty acids, devil’s claw, ginger, thunder god vine, turmeric, and bromelain.



NIH STEM Teaching Resources

The free K‒12 STEM education materials on this site are provided by NIH Institutes and Centers and NIH grantees, including Science Education Partnership Award recipients.

EVENTS

June NIAMS Advisory Council Meeting (Virtual Meeting)

The next NIAMS Advisory Council Meeting will be held virtually on June 7, 2022. The meeting will be available for viewing via the NIH videocasting service. A video recording of the previous NIAMS Advisory Council Meeting on February 1, 2022, is available.



Image
              June NIAMS Advisory Council Meeting (Virtual Meeting)




At the Crossroads of the Microbiome, Metabolism, & Glycoscience

April 29, 2022
9a.m. to 5p.m. ET
Location: VideocastRegistration is required.
View the agenda.

NIH Director’s Wednesday Afternoon Lecture Series

Upcoming Lecture:

May 11, 2022
3 to 4 p.m. ET
John Kuriyan, Ph.D., University of California, BerkeleyMechanisms of Activation of the EGF Receptor

NIH Science Lectures and Events Available via Internet

Look for past videocasts, including:

Rare Disease Day at NIH, February 28, 2022
	Imaging Inflammation Resolution and Wound Repair
	Somatic Mutations in “Benign” Diseases/Somatic Mutations in Rheumatologic Diseases: VEXAS and Beyond (Second half of this Demystifying Medicine lecture is by Peter Grayson, M.D., M.Sc., NIAMS IRP)*For additional online science seminars and events hosted by the NIH, view the NIH VideoCast Future Events and the NIH calendar.* 
    FacebookEmailPrintFacebookEmail
 About NIAMS
                    Clinical Trials
                    Grants & Funding
                    Health Topics
                    Labs @ NIAMS
              News Room
                    NIAMS Multimedia Library
                    Disclaimer
                    FOIA
                    Contact us
              Privacy Statement
                    Accessibility
                    HHS Vulnerability Disclosure
                    Social Media Moderation Policy
                    NIAMS Archives
        Subscribe to Our E-Newsletters
            Click the button to see different options to sign up for newsletters.
            Click Here to Subscribe
          Follow us on
  
  About NIH
                  Accessibility Support
            FOIA requests
                  No FEAR Act data
            Office of the Inspector General
                  Performance reports
            Privacy Policy Back to Top